First Time Loading...
C

Charmacy Pharmaceutical Co Ltd
HKEX:2289

Watchlist Manager
Charmacy Pharmaceutical Co Ltd
HKEX:2289
Watchlist
Price: 14 HKD 1.45%
Updated: May 1, 2024

Profitability Summary

45/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Charmacy Pharmaceutical Co Ltd

Revenue
4.4B CNY
Cost of Revenue
-4.1B CNY
Gross Profit
283.4m CNY
Operating Expenses
-176m CNY
Operating Income
107.5m CNY
Other Expenses
-56.1m CNY
Net Income
51.3m CNY

Margins Comparison
Charmacy Pharmaceutical Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Charmacy Pharmaceutical Co Ltd
HKEX:2289
1.5B HKD
6%
2%
1%
US
Mckesson Corp
NYSE:MCK
70.4B USD
4%
1%
1%
US
Cencora Inc
NYSE:COR
47.7B USD
3%
1%
1%
US
Amerisourcebergen Corp
NYSE:ABC
35.4B USD
3%
1%
1%
US
Cardinal Health Inc
NYSE:CAH
25.1B USD
3%
1%
0%
US
Henry Schein Inc
NASDAQ:HSIC
9B USD
31%
6%
3%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
30%
9%
7%
CN
Huadong Medicine Co Ltd
SZSE:000963
57.6B CNY
31%
9%
7%
CN
Sinopharm Group Co Ltd
HKEX:1099
61.9B HKD
8%
4%
2%
IT
Amplifon SpA
MIL:AMP
7.1B EUR
65%
12%
7%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
51B CNY
12%
3%
1%
Country CN
Market Cap 1.5B HKD
Gross Margin
6%
Operating Margin
2%
Net Margin
1%
Country US
Market Cap 70.4B USD
Gross Margin
4%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 47.7B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 35.4B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 25.1B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
0%
Country US
Market Cap 9B USD
Gross Margin
31%
Operating Margin
6%
Net Margin
3%
Country KR
Market Cap 12.2T KRW
Gross Margin
30%
Operating Margin
9%
Net Margin
7%
Country CN
Market Cap 57.6B CNY
Gross Margin
31%
Operating Margin
9%
Net Margin
7%
Country CN
Market Cap 61.9B HKD
Gross Margin
8%
Operating Margin
4%
Net Margin
2%
Country IT
Market Cap 7.1B EUR
Gross Margin
65%
Operating Margin
12%
Net Margin
7%
Country CN
Market Cap 51B CNY
Gross Margin
12%
Operating Margin
3%
Net Margin
1%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Charmacy Pharmaceutical Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Charmacy Pharmaceutical Co Ltd
HKEX:2289
1.5B HKD
9%
2%
18%
5%
US
Mckesson Corp
NYSE:MCK
70.4B USD
-133%
5%
27%
20%
US
Cencora Inc
NYSE:COR
47.7B USD
509%
3%
20%
15%
US
Amerisourcebergen Corp
NYSE:ABC
35.4B USD
371%
3%
18%
13%
US
Cardinal Health Inc
NYSE:CAH
25.1B USD
-23%
1%
21%
13%
US
Henry Schein Inc
NASDAQ:HSIC
9B USD
11%
4%
10%
7%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
7%
3%
9%
5%
CN
Huadong Medicine Co Ltd
SZSE:000963
57.6B CNY
14%
8%
17%
13%
CN
Sinopharm Group Co Ltd
HKEX:1099
61.9B HKD
13%
2%
18%
8%
IT
Amplifon SpA
MIL:AMP
7.1B EUR
15%
4%
11%
7%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
51B CNY
6%
2%
10%
5%
Country CN
Market Cap 1.5B HKD
ROE
9%
ROA
2%
ROCE
18%
ROIC
5%
Country US
Market Cap 70.4B USD
ROE
-133%
ROA
5%
ROCE
27%
ROIC
20%
Country US
Market Cap 47.7B USD
ROE
509%
ROA
3%
ROCE
20%
ROIC
15%
Country US
Market Cap 35.4B USD
ROE
371%
ROA
3%
ROCE
18%
ROIC
13%
Country US
Market Cap 25.1B USD
ROE
-23%
ROA
1%
ROCE
21%
ROIC
13%
Country US
Market Cap 9B USD
ROE
11%
ROA
4%
ROCE
10%
ROIC
7%
Country KR
Market Cap 12.2T KRW
ROE
7%
ROA
3%
ROCE
9%
ROIC
5%
Country CN
Market Cap 57.6B CNY
ROE
14%
ROA
8%
ROCE
17%
ROIC
13%
Country CN
Market Cap 61.9B HKD
ROE
13%
ROA
2%
ROCE
18%
ROIC
8%
Country IT
Market Cap 7.1B EUR
ROE
15%
ROA
4%
ROCE
11%
ROIC
7%
Country CN
Market Cap 51B CNY
ROE
6%
ROA
2%
ROCE
10%
ROIC
5%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More